How Do I Know if My DCIS is Likely to be Aggressive?
Identifying ductal carcinoma in situ, or DCIS, during screenings can be frightening, but there are ways to identify whether or not your DCIS is likely to become aggressive. Here, Rick Baehner, MD and Senior Director of Pathology at Genomic Health, Inc. explains how DCIS scores can help determine risk of recurrence.
Genomic Health is committed to improving the quality of cancer treatment decisions through the research, development and commercialization of genomic-based clinical laboratory services. The company's lead product, the Oncotype DX breast cancer test, has been shown to predict the likelihood of chemotherapy benefit as well as recurrence in invasive breast cancer and has been shown to predict the likelihood of recurrence in ductal carcinoma in situ (DCIS).
SUBSCRIBE FOR MORE EXPERT INFORMATION AND BREAKING BREAST CANCER NEWS
http://www.youtube.com/user/drjayharness
VISIT BREASTCANCERANSWERS.com FOR INFORMATIVE VIDEOS
http://www.breastcanceranswers.....com/video-categorie
SUBMIT A QUESTION
http://www.breastcanceranswers.com/ask
DOWNLOAD DR. HARNESS' 15 QUESTIONS TO ASK YOUR DOCTOR
http://www.breastcanceranswers.....com/what-breast-can
CONNECT WITH US!
Google+: http://bit.ly/16nhEnr
Facebook: https://www.facebook.com/BreastCancerAnswers
Twitter: https://twitter.com/BreastCancerDr
______
Disclaimer: This information should not be relied upon as a substitute for personal medical advice, diagnosis or treatment. Use the information provided on this site solely at your own risk. If you have any concerns about your health, please consult with a physician.
-
Category
No comments found